Issue Date: June 21, 2010
Drug Safety Reform
When McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, recalled more than 40 types of widely used children’s medicine on April 30, confidence in the safety of the U.S. drug supply took a nose dive. American consumers and members of Congress, already wary of the quality of imported medicine, began questioning whether drugs manufactured in the U.S. are any better than those made overseas.
As J&J tries to rebuild its . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society